Section Arrow
AKYA.NASDAQ
- Akoya BioSciences
Quotes are at least 15-min delayed:2025/07/06 15:20 EDT
Last
 1.36
+0.01 (+0.74%)
Day High 
1.4 
Prev. Close
1.35 
1-M High
1.4 
Volume 
309.67K 
Bid
1.39
Ask
1.4
Day Low
1.35 
Open
1.35 
1-M Low
1.09 
Market Cap 
67.44M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.29 
20-SMA 1.26 
50-SMA 1.21 
52-W High 3.42 
52-W Low 0.931 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.96/-0.63
Enterprise Value
148.30M
Balance Sheet
Book Value Per Share
-0.12
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
81.67M
Operating Revenue Per Share
1.70
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor13.88-0.01-0.07%13.36PE
MBOTMicrobot Medical2.6+0.1+4.00%-- 
ALCAlcon87.78-1.52-1.70%39.69PE
XRAYDENTSPLY SIRONA16.67+0.1+0.60%-- 
COOCooper Companies (The)73.3+0.28+0.38%35.28PE
Quotes are at least 15-min delayed:2025/07/06 15:20 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.